Effects of combined chronic nimodipine and acute metrifonate treatment on spatial and avoidance behavior

European Journal of Pharmacology

Volumn 322, Issue 1, 1997, Pages 1-9

  Riekkinen, Minna ^a   Schmidt, Bernard ^b   Kuitunen, Jani ^a   Riekkinen Jr , Paavo ^a  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b CNS Research   (Germany)

Author keywords

Aged rat; Medial septum lesioned rat; Metrifonate, acute; Motor test; Nimodipine, chronic; Passive avoidance; Washout; Water maze

Indexed keywords

METRIFONATE; NIMODIPINE;

AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN INJURY; COGNITION; CONTROLLED STUDY; LOCOMOTION; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PASSIVE AVOIDANCE; PRIORITY JOURNAL; RAT;

ANIMALS; AVOIDANCE LEARNING; BRAIN CHEMISTRY; CALCIUM CHANNEL BLOCKERS; CHOLINESTERASE INHIBITORS; MALE; MAZE LEARNING; MOTOR ACTIVITY; NIMODIPINE; RATS; RATS, WISTAR; SPACE PERCEPTION; TRICHLORFON;

EID: 0030936698     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(96)00976-4     Document Type: Article

References (42)

1. 2+ Antagonist in the CNS, eds. A. Scriabine, R.A. Janis and D.J. Triggle, p. 307.
2. Bartus, R.T., R.L. Dean, M.J. Pontecorvo and C. Flicker, 1985, The cholinergic hypothesis: a historical overview, current perspective, and future directions, Ann. NY Acad. Sci. 444, 332.
3. Becker, R.E. and E. Giacobini, 1988, Mechanisms of cholinesterase inhibition in senile dementia of the Alzheimer type: clinical, pharmacological, and therapeutic aspects, Drug Dev. Res. 12, 163.
4. Björklund, M., P. Jäkälä, B. Schmidt, M. Riekkinen, E. Koivisto and P. Riekkinen, 1996, An indirect cholinesterase inhibitor, metrifonate, increases neocortical EEG arousal in rats, NeuroReport (in press).
5. Blokland, A., V. Hinz and B.H. Schmidt, 1995, Effects of metrifonate and tacrine in the spatial Morris task and modified Irwin test: evaluation of the efficacy/safety profile in rats, Drug Dev. Res. 36, 166.
6. Bowen, D.M., S.J. Allen, J.S. Benton, M.J. Goodhardt, E.A. Haan, A.M. Palmer, N.R. Sims, C.C.T. Smith, J.A. Spillane, G.K. Esira, D. Neary, J.S. Snowden, G.K. Wilcock and A.N. Davison, 1983, Biochemical assessment of serotonergic and cholinergic dysfunction and cerebral atrophy in Alzheimer's disease, J. Neurochem. 41, 266.
7. Decker, M.W., 1987, The effects of aging on hippocampal and cortical projections of the forebrain cholinergic system, Brain Res. Rev. 12, 423.
8. De Jong, G.I., H. De Weerd, T. Schuurman, J. Traber and P.G.M. Luiten, 1990, Microvascular changes in the aged rat forebrain. Effects of chronic nimodipine treatment, Neurobiol. Aging 11, 381.
9. Dunnett, S.B., B.J. Everitt and T.W. Robbins, 1991, The basal forebrain-cortical cholinergic systems: interpreting the functional consequences of excitotoxic lesions, Trends Neurosci. 14, 494.
10. Eagger, S.A. and R.J. Harvey, 1995, Clinical heterogeneity: responders to cholinergic therapy, Alzheimer Dis. Assoc. Disord. 9 (Suppl. 2), 37.
11. 2+ Antagonist in the CNS, eds. A. Scriabine, R.A. Janis and D.J. Triggle, p. 407.
12. 2+ Antagonist in the CNS, eds. A. Scriabine, R.A. Janis and D.J. Triggle, p. 379.
13. Fonnum, F., 1975, A rapid radiochemical method of the determination of choline acetyltransferase, J. Neurochem. 24, 707.
14. Hagan, J.J. and R.G.M. Morris, 1988, The cholinergic hypothesis of memory: a review of animal experiments, in: Psychopharmacology of the Aging Nervous System. Handbook of Psychopharmacology, Vol. 20, eds. L.L. Iversen, S.D. Iversen and S.H. Snyder (Plenum Press, New York, NY) p. 237.
15. Hinz, V.C., A. Blokland, F.J. Van der Staay, I. Gebert, T. Schuurman and B.H. Schmidt, 1996, Receptor interaction profile and CNS general pharmacology of metrifonate and its transformation product dichlorvos in rodents, Drug Dev. Res. (in press).
16. Ingram, D.K., J.A. Joseph, E.L. Spanger, D. Roberts, J. Hengemihle and R.J. Fanelli, 1994, Chronic nimodipine treatment in aged rats: analysis of motor and cognitive effects and muscarinic-induced dopamine release, Neurobiol. Aging 15, 55.
17. Jäkälä, P., M. Riekkinen, B. Schmidt, M. Björklund, E. Koivisto and P. Riekkinen Jr., 1996, Effects of combined nimodipine and metrifonate on rat cognition and corticol EEG, Eur. J. Pharmacol. 318, 239.
18. Khachaturian, Z.S., 1984, Towards theories of brain aging, in: Handbook of Studies of Psychiatry and Old Age, ed. K.D. Burrows (Elsevier, Amsterdam).
19. Knapp, M.J., D.S. Knopman, P.R. Solomon, W.W. Pendlebury, C.S. Davis and S.I. Gracon, 1992, A 30-week randomized controlled trial of high-dose tacrine in patients with Alzheimer's disease, J. Am. Med. Assoc. 271, 985.
20. Kronforst Collins, M.A., P.L. Moriearty, M. Ralph, R.E. Becker, B. Schmidt, L.T. Thompson and J.F. Disterhoft, 1996, Metrifonate treatment enhances acquisition of eyeblink conditioning in aging rabbits, Pharmacol. Biochem. Behav. (in press).
21. LeVere, T.E. and A. Walker, 1991, Old age and cognition: enhancement of recent memory in aged rats by a calcium channel blocker nimodipine, Neurobiol. Aging 13, 63.
22. LeVere, T.E., T. Brugler, M. Sandin and S. Gray-Silva, 1989, Recovery of function after brain damage: facilitation by the calcium entry blocker nimodipine, Behav. Neurosci. 103, 561.
23. 2+ Antagonist in the CNS, eds. A. Scriabine, R.A. Janis and D.J. Triggle, p. 71.
24. Miettinen, R., J. Sirviö, P. Riekkinen Sr., M. Laakso, M. Riekkinen and P. Riekkinen Jr., 1993, Neocortical, hippocampal and septal parvalbumin- and somatostatin-containing neurons in young and aged rats: correlation with passive avoidance and water maze performance, Neuroscience 53, 367.
25. Peterson, C. and J. Goldman, 1986, Alterations in calcium content and biochemical processes during aging and Alzheimer's disease, Proc. Natl. Acad. Sci. USA 83, 2758.
26. Riekkinen, P., G. Buzsáki, P. Riekkinen Jr., H. Soininen and J. Partanen, 1991, The cholinergic system and EEG slow waves, Electroencephalogr. Clin. Neurophysiol. 78, 89.
27. Riekkinen Jr., P., M. Aaltonen, J. Sirviö and P. Riekkinen, 1991a, Tetrahydroaminoacridine alleviates medial septal lesion-induced and age-related spatial reference but not working memory deficits, Physiol. Behav. 49, 1147.
28. Riekkinen Jr., P., P. Jäkälä, J. Sirviö and P. Riekkinen, 1991b, The effects of THA on scopolamine and nucleus basalis lesion-induced EEG-slowing, Brain Res. Bull. 26, 633.
29. Riekkinen Jr., P., M. Riekkinen, H. Lahtinen, J. Sirviö, A. Valjakka and P. Riekkinen, 1991c, Tetrahydroaminoacridine improves passive avoidance retention defects induced by aging and medial septal lesion but not by fimbria-fornix lesion, Brain Res. Bull. 27, 587.
30. Riekkinen Jr., P., J. Sirviö, M. Riekkinen and P. Riekkinen, 1991d, EEG changes induced by acute and chronic quisqualic or ibotenic acid nucleus basalis lesions are stabilized by tacrine, Brain Res. 559, 304.
31. Riekkinen Jr., P., J. Sirviö, M. Riekkinen and P. Riekkinen, 1991e, Effects of THA on passive avoidance retention performance of intact nucleus basalis, frontal cortex and nucleus basalis + frontal cortex-lesioned rats, Pharmacol. Biochem. Behav. 39, 841.
32. Riekkinen Jr., P., M. Riekkinen, T. Ekonsalo, A. Fisher and J. Sirviö, 1993, Effects of muscarinic receptor agonists and anticholinesterase drugs on high voltage spindles and slow waves, Eur. J. Pharmacol. 240, 1.
33. Riekkinen Jr., P., B. Schmidt, R. Stefanski, J. Kuitunen and M. Riekkinen, 1996, Metrifonate improves spatial navigation and passive avoidance behavior in scopolamine-treated, medial septal-lesioned and aged rats, Eur. J. Pharmacol. 309, 121.
34. Sandin, M., S. Jasmin and T. LeVere, 1990, Aging and cognition: facilitation of recent memory in aged nonhuman primates by nimodipine, Neurobiol. Aging 11, 573.
35. Schuurman, T. and J. Traber, 1989, Effects of nimodipine on behavior of old rats, in: Nimodipine and Central Nervous System Function: New Vistas, eds. J. Traber and W.H. Gispen (Schattauer, Stuttgart) p. 195.
36. Scribane, A., T. Schuurman and J. Traber, 1989, Pharmacological basis for the use of nimodipine in central nervous system disorders, FASEB J. 3, 1799.
37. Soininen, H., K. Reinikainen, J. Partanen, E.-L. Helkala, L. Paljärvi and P. Riekkinen, 1992, Slowing of electroencephalogram and choline acetyltransferase activity in post mortem frontal cortex in definite Alzheimer's disease, Neuroscience 49, 529.
38. Van der Staay, F.J., V.C. Hinz and B.H. Schmidt, 1996, Effects of metrifonate on escape distance and avoidance learning in young and aged rats, Behav. Pharmacol. 7, 56.
39. Watkins, P.B., H.J. Zimmerman, M.J. Knapp, S.I. Gracon and K.W. Lewis, 1994, Hepatotoxic effects of tacrine administration in patients with Alzheimer's disease, J. Am. Med. Assoc. 271, 991.
40. Wenk, G.L., L.C. Walker, D.L. Price and L.C. Cork, 1991, Loss of NMDA, but not GABA-a, binding in the brains of aged rats and monkeys, Neurobiol. Aging, 12, 93.
41. Whitehouse, P.J., D.L. Price, R.G. Struble, A.W. Clark, J.T. Coyle and R.M. DeLong, 1982, Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain, Science 215, 1237.
42. Yamada, S., S. Uchida, T. Ohkura, R. Kimura, Y. Yamaguchi, M. Suzuki and M. Yamamoto, 1996, Alterations in calcium antagonist receptors and calcium content in senescent brain and attenuation by nimodipine and nicardipine, J. Pharmacol. Exp. Ther. 277, 721.